LINE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LINE is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The chart is constructive and the stock is trading above key moving averages, but the fundamental picture is mixed: revenue growth is essentially flat, the company posted a net loss last quarter, hedge funds are selling aggressively, and analyst views are divided. For an impatient buyer, this is more of a wait-for-better-confirmation name than an immediate long-term buy.
Technically, LINE is in a short-term bullish trend. MACD histogram is positive and expanding, RSI_6 at 59.68 is neutral-to-bullish, and the moving average stack is bullish with SMA_5 > SMA_20 > SMA_200. Price at 44.01 is just above pivot support at 42.576 and below first resistance at 44.524, with near-term upside toward 45.727 if momentum continues. Overall, the setup is positive, but not strong enough alone to justify an aggressive long-term entry.
["Analysts have recently raised price targets, with Scotiabank to $45, Truist to $46, and Morgan Stanley to $47.", "Scotiabank cited improving USDA cold storage data and signs of demand stabilization.", "Truist expects the REIT to return to earnings growth in 2027, with upside beyond that.", "Technicals are supportive, with bullish moving averages and expanding positive MACD momentum.", "Option positioning leans bullish based on low put-call ratios."]
["Lineage reported FY 2025 revenue of about $5.4B with only 0.3% growth and a net loss of nearly $98M.", "Hedge funds are selling, with selling up 379.67% over the last quarter.", "Barclays remains bearish with an Underweight rating and a $35 target.", "The latest financial snapshot shows debt-to-equity around 1.0 and current ratio at 0.8, indicating weaker balance-sheet flexibility.", "Analyst sentiment is mixed overall, with several ratings still only Equal Weight or Sector Perform.", "The stock has fallen about 45% since the 2024 IPO, showing weak long-term post-IPO performance.", "No recent insider buying and no recent congress trading data were found."]
For the latest fiscal year/quarterly context provided, Lineage’s FY 2025 revenue was approximately $5.4 billion, up only 0.3% year over year, which signals very slow growth. The company also reported a net loss of nearly $98 million, so profitability remains weak. The available snapshot suggests leverage near 1.0 debt-to-equity and a current ratio of 0.8, which is not particularly strong. The latest season is FY 2025, and the main takeaway is stagnating growth with losses still present.
Recent analyst action has turned slightly more constructive on price targets, but ratings remain split. Scotiabank lifted its target to $45 and kept Sector Perform, Truist raised to $46 and kept Buy, and Morgan Stanley increased to $47 while maintaining Equal Weight. On the bearish side, Barclays remains Underweight with a $35 target and has highlighted industry headwinds. Wall Street’s pro view is that demand is stabilizing, cold storage data is improving, and earnings growth may reaccelerate later; the con view is that industry challenges, weak profitability, and supply/demand pressure still limit conviction.
